Aztreonam

Azonam is indicated for the treatment of the following infections caused by susceptible Gram-negative microorganisms. It is used for urinary tract infections, complicated and uncomplicated, including pyelonephritis and cystitis, whether initial or recurrent, caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella oxytoca, Citrobacter species and Serratia marcescens. It is also used for lower respiratory tract infections, including pneumonia and bronchitis, caused by Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species and Serratia marcescens. It is used for septicemia caused by Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, Serratia marcescens and Enterobacter species, as well as for skin and skin-structure infections, including those associated with postoperative wounds, ulcers and burns, caused by Escherichia coli, Proteus mirabilis, Serratia marcescens, Enterobacter species, Pseudomonas aeruginosa, Klebsiella pneumoniae and Citrobacter species. It is further indicated for intra-abdominal infections, including peritonitis, caused by Escherichia coli, Klebsiella species including K. pneumoniae, Enterobacter species including E. cloacae, Pseudomonas aeruginosa, Citrobacter species including C. freundii and Serratia species including S. marcescens, and for gynecologic infections, including endometritis and pelvic cellulitis, caused by Escherichia coli, Klebsiella pneumoniae, Enterobacter species including E. cloacae and Proteus mirabilis. It may also be used as adjunctive therapy to surgery in the management of infections caused by susceptible organisms.